DTC
Deep Track Capital Portfolio holdings
AUM
$3.11B
1-Year Return
13.6%
This Quarter Return
-3.3%
1 Year Return
+13.6%
3 Year Return
+265.73%
5 Year Return
–
10 Year Return
–
AUM
$2.58B
AUM Growth
+$438M
(+20%)
Cap. Flow
+$513M
Cap. Flow
% of AUM
19.91%
Top 10 Holdings %
Top 10 Hldgs %
46.08%
Holding
70
New
15
Increased
18
Reduced
13
Closed
6
Top Buys
| 1 |
Guardant Health
GH
|
$75.6M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$54.8M |
| 3 |
Axsome Therapeutics
AXSM
|
$52.9M |
| 4 |
Apogee Therapeutics
APGE
|
$51.4M |
| 5 |
NovoCure
NVCR
|
$40.4M |
Top Sells
| 1 |
Immunovant
IMVT
|
$101M |
| 2 |
Structure Therapeutics
GPCR
|
$36.9M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
$14.5M |
| 4 |
Insmed
INSM
|
$12.6M |
| 5 |
INZY
Inozyme Pharma
INZY
|
$9.16M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Relmada Therapeutics
RLMD
$47.1M
| $8.51M | 0.33% |
2,837,818
| – | – |
|
52
Astria Therapeutics
ATXS
$377M
| $7.74M | 0.3% |
1,037,873
-659,542
| -39% | -$4.92M |
|
53
10x Genomics
TXG
$1.64B
| $7.54M | 0.29% |
+182,691
| New | +$7.54M |
|
54
Novavax
NVAX
$1.18B
| $7.24M | 0.28% |
+1,000,000
| New | +$7.24M |
|
|
SLRN
55
DELISTED
ACELYRIN
SLRN
| $5.61M | 0.22% |
+551,289
| New | +$5.61M |
|
56
GH Research
GHRS
$860M
| $5.02M | 0.19% |
499,400
| – | – |
|
|
SYRS
57
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $3.27M | 0.13% |
+828,485
| New | +$3.27M |
|
58
Scholar Rock
SRRK
$3.16B
| $2.51M | 0.1% |
+353,855
| New | +$2.51M |
|
|
CMPS
59
Compass Pathways
CMPS
$467M
| $2.43M | 0.09% |
328,424
-349,936
| -52% | -$2.59M |
|
60
Heron Therapeutics
HRTX
$198M
| $2.15M | 0.08% |
2,086,704
| – | – |
|
61
89bio
ETNB
$1.32B
| $1.41M | 0.05% |
91,078
-412,022
| -82% | -$6.36M |
|
62
Century Therapeutics
IPSC
$40.4M
| $1.09M | 0.04% |
543,008
-479,884
| -47% | -$960K |
|
|
ALLK
63
DELISTED
Allakos
ALLK
| – | – |
-228,277
| Closed | -$995K |
|
64
FibroGen
FGEN
$48.5M
| – | – |
0
| – | – |
|
65
Immunic
IMUX
$75.8M
| – | – |
-308,314
| Closed | -$774K |
|
66
MiNK Therapeutics
INKT
$63.5M
| – | – |
-32,487
| Closed | -$682K |
|
|
INZY
67
DELISTED
Inozyme Pharma
INZY
| – | – |
-1,644,021
| Closed | -$9.16M |
|
68
MoonLake Immunotherapeutics
MLTX
$3.73B
| – | – |
-108,450
| Closed | -$5.53M |
|
69
Prothena Corp
PRTA
$440M
| – | – |
0
| – | – |
|
70
Zentalis Pharmaceuticals
ZNTL
$120M
| – | – |
-300,300
| Closed | -$8.47M |
|